Cypress Capital Group’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$21.5K	–	295
2023 Q2	$21.5K	Buy	+10,000	New	+$21.5K	﹤0.01%	298
2022 Q4	–	Sell	-10,000	Closed	-$48K	–	292
2022 Q3	$48K	Hold	10,000	–	–	0.01%	274
2022 Q2	$80K	Buy	+10,000	New	+$80K	0.01%	277